Out of 242 cases of ovarian cancer tissues, we showed that SPON1 was weakly, moderately, and strongly expressed in 87 (36.0%), 64 (26.4%), and 22 (9.1%), respectively. This evidence concerns the gene SPON1 and ovarian carcinoma.